Aldagen plans IPO worth up to $80.5 million

newsobserver.com     May 12, 2008            

A small Durham biotechnology company is planning to sell stock to the public to raise as much as $80.5 million, according to a filing with the Securities and Exchange Commission. ... By Sabine Vollmer, Staff Writer A small Durham biotechnology company is planning to sell... [read full story]                

Full Coverage

Biopharmaceutical company Aldagen plans IPO

ibtimes.com     May 10, 2008          

Aldagen Inc., a biopharmaceutical company developing treatments from adult stem cells, plans an initial public offering of common stock, according to a Securities and Exchange Commission filing on Friday. ... Aldagen did not disclose the expected size or price range of...                

comments